CHRISTIANA IKOME: Open Payments
NPI 1043682685 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 34 payments from 10 companies in 2025. Trend: 2023 $105 · 2024 $547 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $209 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Supernus Pharmaceuticals, Inc. | 5 | $89 |
| Tris Pharma Inc | 4 | $72 |
| Collegium Pharmaceutical, Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Corium, LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, HETLIOZ, Qelbree, Jornay PM, REXULTI, Onyda XR, Quillivant, SPRAVATO.
Industry payments across MD — which companies pay providers there.
